Skip to main content

Deposited paper deposited in the House of Lords by the Department of Health on Tuesday, 8 December 2015. The commitment to deposit was made on Friday, 9 December 2011.


Deposited Paper DEP2015-0961

I. Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation. Technology appraisal guidance. 41p. II. NICE implementation collaborative consensus: supporting local implementation of NICE guidance on the use of the novel (non-Vitamin K antagonist) oral anticoagulants in non-valvular atrial fibrillation. 14p. III. Innovation health and wealth: accelerating adoption and diffusion in the NHS.

Associated files
https://data.parliament.uk/DepositedPapers/files/DEP2015-0961/innovation_health_and_wealth.pdf
https://data.parliament.uk/DepositedPapers/files/DEP2015-0961/nic-consensus-statement-on-the-use-of-noacs.pdf
https://data.parliament.uk/DepositedPapers/files/DEP2015-0961/rivaroxaban-for-people-with-atrial-fibrillation.pdf

Secondary information

Type
Deposited paper
Reference
DEP2015-0961 
Originated on
Wednesday, 23 May 2012
Author
National Institute for Health and Care Excellence
Department of Health
Related items
Atrial Fibrillation: Screening
Tuesday, 8 December 2015
Written questions
House of Lords
Atrial Fibrillation: Diagnosis
Tuesday, 8 December 2015
Written questions
House of Lords
Atrial Fibrillation: Strokes
Tuesday, 8 December 2015
Written questions
House of Lords
Atrial Fibrillation: Strokes
Tuesday, 8 December 2015
Written questions
House of Lords
Subjects
Drugs Innovation NHS Primary care National Institute for Health and Care Excellence Strokes Risk assessment Anticoagulants Atrial fibrillation